Stockreport

Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround Game [Seeking Alpha]

Pfizer, Inc.  (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
PDF Obesity drugs, particularly via Metsera, represent a potential $150B TAM, though market skepticism persists until Phase III data matures. PFE's forward multiple of 9. [Read more]